Tomoharu Yamada

4PUBLICATIONS
6CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersBehavioural epidemiologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 03, 2026
Toward a Synthetic Data Revolution: Diffusion Model-Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease.

|Oct 01, 2025
Pre-Treatment Liver Stiffness Is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post-Treatment Liver Stiffness After Hepatitis C Virus Eradication.

Takuma Nakatsuka, Ryo Nakagomi, Keisuke Mabuchi

|May 30, 2025
Predicting the risk of developing diabetes in steatotic liver disease using controlled attenuation parameter in a health checkup population.

Takuma Nakatsuka, Yutaka Yamaji, Ryosuke Tateishi

|Jul 21, 2021
Limited efficacy of atezolizumab and bevacizumab for hepatocellular carcinoma previously treated with tyrosine kinase inhibitor.

Tomoharu Yamada, Tatsuya Minami, Ryosuke Tateishi

Pageof 1

Frequent Collaborators

4 joint publications

Ryosuke Tateishi

3 joint publications

Takuma Nakatsuka

3 joint publications

Masaya Sato

2 joint publications

Yotaro Kudo